comparemela.com
Latest Breaking News On - Sande score - Page 1 : comparemela.com
Key Takeaways from Phase 4 Switch Trial Presented at AAO
Richard Adler, MD, FACS, discusses the Switch trial which compared OTX-101 (cyclosporine ophthalmic solution 0.09%) vs cyclosporine ophthalmic emulsion 0.05% (Restasis) in patients with dry eye disease (DED).
Managing-dry-eye-disease
Trial-presented
Cequa
Open-label
Single-arm-study
Incomplete-response
Restasis
Dry-eye-disease
Corneal-staining
Sande-score
Symptom-assessment-questionnaire-in-dry-eye-corneal-staining
vimarsana © 2020. All Rights Reserved.